With the capital raised to date, the company has extended its cash runway until the end of the first quarter of 2027.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics Enters Securities Purchase Agreement
- Intensity Therapeutics prices 5M shares at 80c in registered direct offering
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Why Is Intensity Therapeutics Stock (INTS) Up 195% Today?
- Intensity Therapeutics’ INT230-6 antitumor effect featured in published study
